The report covers the analysis of global as well as regional markets of Drug Discovery Technologies. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
The report on Drug Discovery Technologies Market by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Drug Discovery Technologies Market is projected to grow at a CAGR of 18.4% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
The Business Research Company added a report “Artificial Intelligence (AI) In Drug Discovery Market” to its collection – which covers the industry overview with size, share, development, demand and distribution. https://bit.ly/2EcMAyX
Drug Discovery Informatics Market size was USD 1.6 billion in 2015 and is anticipated to reach around USD 6.5 billion by 2023. Get more details @ https://goo.gl/UgKpgf
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. See Full Report @ bit.ly/1vM6jVN
Biomarker technology is evidencing increased application from key segments such as disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. See Full Report @ http://bit.ly/1zB1l1W
The global artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.05 billion by 2028 according to a new study by Polaris Market Research.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics...... @ @ https://bit.ly/3D4dtix
This report studies the global Drug Discovery Services market, analyzes and researches the Drug Discovery Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
The global drug discovery informatics market size is expected to reach USD 5.62 billion by 2028 according to a new study by Polaris Market Research. The report “Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow (Discovery Informatics, Development Informatics); By Mode (Outsourced, In-house); By Services (Sequence Analysis Platforms, Molecular Modeling, Docking, Clinical Trial Data Management, Others); By Regions; Segment Forecast, 2021 – 2028”
The global artificial intelligence (AI) in drug discovery market is expected to grow from $0.36 billion in 2020 to $0.47 billion in 2021 at a compound annual growth rate (CAGR) of 30.6%.
Global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025.
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals... @@ https://bit.ly/3y2JLrb
Big Market Research “Global Drug Discovery Informatics Market 2022” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast
The global market for RNAi drug delivery technologies reached nearly $9.3 billion in 2012 and nearly $11.7 billion in 2013. This market is expected to grow to $38.8 billion in 2018, with a compound annual growth rate(CAGR) of 27.2% from 2013 to 2018.
The biochip market is expected to witness significant growth throughout the forecast period because of an increasing application of biochips in genomics, proteomics and drug discovery.
Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to a fraction of antibodies. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.
JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ http://goo.gl/CYCwde
The metabolomics market is projected to reach USD 2.2billionin the forecasted period. North America contributed up to 45% of market share making it a market leader in metabolomics market.
The protein binding assay market is projected to reach US$ 694.63 million by 2028 from US$ 340.14 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.
The global CRISPR Technology Market is projected to reach USD 3.94 billion by 2027, according to a recent report by Emergen Research. Certain factors that are driving the market growth include increasing government and personal funding, rising demand and adoption of CRISPR, and technological advancements.
Rising awareness about cell culture media has led to the rise in its demand, adoption and conclusively a rise in its market value. Data Bridge Market Research analyses that the cell culture media will exhibit a CAGR of around 8.18% for the forecast period of 2021-2028. https://www.databridgemarketresearch.com/reports/global-cell-culture-media-market
Glycomics refers to an extensive study of the physiological, genetic, and pathological, among other aspects of glycomas. Glycomics kit includes glycan release kits, glycan purification kits, and glycan labelling kits among others. These are highly deployed in applications such as oncology, drug & discovery & development, diagnostics, and immunology, among others.
The Bioinformatics Market research report covers key players, trends, status, future forecast, size-share, development trends, challenges, opportunities and consumer behavior’s. It provides insight into the growth of value players, as well as looking at new entrants to the market and their growth prospects.
The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.
Analgesics: drug discovery Jenny Laird AstraZeneca Research & Development Montr al Choosing a target for drug discovery should cover an unmet medical need has ...
Increased spending in cancer-related research and development by various governments and private and commercial organizations combined with investments in anti-cancer drugs are the two key factors anticipated to heighten the generic oncology drugs demand, through 2019, as indicated in a recent market analysis of generic oncology drugs, by Persistence Market Research (PMR).
Bharat Book Bureau provides the report; on “ADME/Tox Technologies Market Research Reports”. This Report on Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered. https://www.bharatbook.com/biotechnology-market-research-reports-227827/adme-tox-technologies1.html
Statistics of Animal Model Market covering market size, industry share numbers, regional outlook, competitive landscape with data about leading companies is now available in the latest report by Global Market Insights, Inc.
Growing applications in molecular diagnosis and cancer diagnosis, adoption of synthetic delivery carriers and technological upgradation in the form of chemical modification to RNA are some of the factors that will enhance the growth of the market in the forecast period of 2020-2027. On the other hand, increasing research and development will further create new opportunities for the growth of RNA interference market in the above mentioned forecast period.
Breakthrough therapy designation and orphan drug approvals for microbiome therapeutics is expected to accelerate the launch of developmental drugs in the microbiome therapeutics market. A huge pipeline with over 120 candidates in different stages of development further creates the platform for potential growth of the microbiome therapeutics market.
APAC AI in Healthcare Market has been facilitated by increasing awareness about the application of artificial intelligence in healthcare which will further be complemented by supportive legislation and regulations.
According to a new market report published by Persistence Market Research “Global Market Study on Osteoporosis Drugs: Asia Pacific to Witness Highest Growth by 2022”, the global osteoporosis drugs market is estimated to be valued at US$11,226.1 Mn by the end of 2015 and is expected to expand at a CAGR of 4.0% from 2014 to 2022, to account for US$14,786.7 Mn by 2022.
Aarkstore.com announces, The Latest market research report is available in its vast collection "Stem Cell Research Products - Opportunities, Tools, and Technologies"
Global Digital Genome Market Information by Disease (cancer, diabetes), by End users hospitals, research laboratories) by application (diagnostics, drug discovery, academic research) - Forecast to 2027
Avail more information from Sample Brochure of report @ http://bit.ly/2dlXJ2P The study covers and analyses “Global Mammalian Market”. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiative and technologies related to the market. In addition, it will help the venture capitalist in understanding the companies better and take informed decisions. Read analysis @ http://bit.ly/2cYaYDP
According to a new market report published by Persistence Market Research “Global Market Study on Osteoporosis Drugs: AsiaPacific to Witness Highest Growth by 2022”, the global osteoporosis drugs market is estimated to be valued at US$11,226.1 Mn by the end of 2015 and is expected to expand at a CAGR of 4.0% from 2014 to 2022, to account for US$14,786.7 Mn by 2022.
Expanding at a rather high CAGR of nearly 6.7 percent, small molecule generic oncology drugs, combing the efficacies of chemotherapy and immunotherapies could boost the ongoing cancer treatment modalities.
Healthcare Artificial Intelligence Market size was over USD 750 million in 2016 and forecast to witness nearly 40% CAGR from 2017 to 2024. Get more details @ https://goo.gl/J6Tkjq
The market is driven by factors, such as technological advancements and innovations, increasing compliance for drug discovery processes, and high demand for organ and tissue transplantation.
The report provides drug profiles which include product description, MOA, technology, licensors & collaborators, development partner and detailed chemical information.
Contract Research Organization (CRO) Market Research Report, By Segment (Drug Discovery, Clinical Development), By Clinical Trial Phase (Preclinical Trials, Phase I, Phase II, Phase III), By End Users (Pharmaceutical Companies) - Global Forecast till 2023
Download Sample Brochure @ http://bit.ly/2cUzvLT Cardiovascular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. Read Analysis @ http://bit.ly/2dxrN8n
Download Sample Brochure @ http://bit.ly/2dEhRvj DelveInsight’s, “ Xerostomia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Xerostomia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Read Analysis @ http://bit.ly/2dwYulS